Stay updated on ACTIV-2 Outpatient COVID-19 Clinical Trial
Sign up to get notified when there's something new on the ACTIV-2 Outpatient COVID-19 Clinical Trial page.

Latest updates to the ACTIV-2 Outpatient COVID-19 Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedAdded a government-funding notice with current operating status for NIH Clinical Center and updated version to v3.2.0; removed the previous version reference v3.1.0.SummaryDifference0.6%

- Check32 days agoChange Detected- Added version indicator Revision: v3.1.0. - Removed several substantive topics (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs) and retained a prior version Revision: v3.0.2, suggesting a reorganization and narrowing of content scope with a move to a newer version.SummaryDifference0.1%

- Check46 days agoChange DetectedRevision updated from v3.0.1 to v3.0.2, and the 'Back to Top' control was removed; no changes to core content or pricing.SummaryDifference0.0%

- Check53 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content or other important elements.SummaryDifference0.0%

- Check60 days agoChange DetectedThe web page has been updated to include new facility names and locations, as well as additional drug information related to COVID-19 treatments. Notably, several specific locations in the United States, Argentina, Brazil, Mexico, and South Africa have been added, enhancing the geographical coverage of the content.SummaryDifference8%

- Check67 days agoChange DetectedThere are no significant changes to the web page content.SummaryDifference0.3%

Stay in the know with updates to ACTIV-2 Outpatient COVID-19 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ACTIV-2 Outpatient COVID-19 Clinical Trial page.